Skip to main
University-wide Navigation

UK, Partners Break Ground on New Coldstream Research Lab

The new facility will be named “The Core — Collaboration. Research. Entrepreneurship,” and is designed to be the first stop for companies looking to locate on the research campus.

OTC Receives EDA Grant to Fund Growth of Launch Blue

UK's Office of Technology Commercialization (OTC), on behalf of UK Research Foundation (UKRF), was awarded a three-year $600,000 grant from the Economic Development Administration (EDA) Build to Scale Program, one of 52 projects funded from 36 states.

CAER Receives U.S. DOE Grant to Develop Next-Generation Carbon Dioxide Capture Technology

“This project will allow us to significantly reduce the complexity and cost of CO2 capture and biofixation from all sources, whether it is from utility companies, cement manufacturing, or chemical plants."

UK’s James B. Beam Institute for Kentucky Spirits Inks Powerful Partnership With Scotch Whisky Research Institute

“This is a great opportunity to carry our efforts beyond Kentucky and the United States,” said Seth DeBolt, director of the James B. Beam Institute for Kentucky Spirits. “To partner with such an established institute will elevate the efforts we’ve already begun at the Beam Institute.”

College of Pharmacy Receives $11.8 Million to Further Substance Use Disorder Research

The funding will further ongoing substance use disorder treatment research in collaboration with Sharon Walsh at the UK Center on Drug and Alcohol Research (CDAR) and Mei-Chuan Ko at the Wake Forest School of Medicine.

COVID-19 Vaccine Candidate Tested at UK Shows Positive Preclinical Results

PDS0203 stands out among COVID-19 vaccines currently in development because it includes a vaccine technology pioneered by PDS Biotech called Versamune®, which stimulates important parts of the immune system to activate T cells.

UK Part of Nationally Unique Partnership to Commercialize Tech Innovations

“We all want to grow Kentucky’s tech sector and create the high-paying, knowledge-based jobs that follow. A big part of doing so is turning Kentucky’s own academic research and development capabilities into commercially viable products and startups.”

NIH-funded Network Led by XLerateHealth and UK Supports HBCU Commercialization

Supported by XLerateHealth, a health care startup accelerator in Louisville, Kentucky, and by UK, EnRICH is an outgrowth of NIH funding UK received in October 2018 — $3.5 million over three years — to create the XLerator Network.

Artemisia Annua Could Be Promising Treatment for COVID-19

The new potential treatment has been added to the University of Kentucky’s innovative clinical trial for experimental COVID-19 therapies, which was launched by leaders from UK’s Markey Cancer Center, College of Medicine and College of Pharmacy in May.

UK's Korotkov Partners With Atomwise to Screen for Potential Drugs Against Novel COVID-19 Target

UK announced a research collaboration with Atomwise, an industry leader in using artificial intelligence (AI) for small molecule discovery, to explore potential COVID-19 therapies.

Filter News